Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
MedlinePlus | a682660 |
Pregnancy category |
|
ATC code | |
Identifiers | |
|
|
Synonyms | (6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.006.402 |
Chemical and physical data | |
Formula | C22H29FO4 |
Molar mass | 376.462 g/mol |
3D model (Jmol) | |
|
|
|
|
(what is this?) |
Fluorometholone (INN, BAN, JAN) (brand names Efflumidex, Flucon, FML Forte, FML, others), also known as 6α-methyl-9α-fluoro-11β,17α-dihydroxypregna-1,4-diene-3,20-dione, is a synthetic glucocorticoid which is used in the treatment of inflammatory eye diseases. The C17α acetate ester, fluorometholone acetate (brand name Flarex), is also a glucocorticoid and is used for similar indications. Specifically, it is indicated for use in the treatment of steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye.
Most common indication for this drug is seasonal allergic conjunctivitis and other allergies of the eye.